美国胸外科医师学会2023年心房颤动外科治疗临床实践指南
该指南纳入近5年关于外科消融与左心耳封堵的新证据,更新2017版推荐。新增强调首次非急诊心脏手术中外科消融的长期获益,将外科消融推荐扩展至所有房颤患者,并对左心耳封堵给出I类推荐。同时为结构性心脏病合并房颤拟行经导管瓣膜介入者及需孤立左心耳处理者提供指导,并重申多学科团队评估与长期随访的I类推荐。
要点
- 首次非急诊心脏手术的房颤患者应行外科消融(推荐级别较2017版扩展)。
- 首次非急诊心脏手术的房颤患者应行左心耳封堵(I类推荐)。
- 多学科团队评估、治疗计划及长期随访获I类推荐。
核心结论
- 新证据支持在首次非急诊心脏手术中扩大外科消融适应证并新增左心耳封堵的I类推荐。
研究设计与样本
- 美国胸外科医师学会制定,基于近5年新证据更新2017版临床实践指南。
主要发现
- 近5年产生关于外科左心耳封堵风险与获益及外科消融长期获益的大量新证据。
关键数值与推荐
- 首次非急诊心脏手术的房颤患者行外科消融获推荐,较2017版扩展至全部此类患者。
- 首次非急诊心脏手术的房颤患者行左心耳封堵为I类推荐。
- 多学科团队评估、治疗计划及长期随访为I类推荐。
- 2017版指南中推荐级别与证据水平未变的其余推荐继续沿用。
临床怎么用
- 原文未据此给出具体临床操作推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Society of Thoracic Surgeons 2023 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation incorporate the most recent evidence for surgical ablation and left atrial appendage occlusion in different clinical scenarios. Substantial new evidence regarding the risks and benefits of surgical left atrial appendage occlusion and the long-term benefits of surgical ablation has been produced in the last 5 years. Compared with the 2017 clinical practice guideline, the current update has an emphasis on surgical ablation in first-time, nonemergent cardiac surgery and its long-term benefits, an extension of the recommendation to perform surgical ablation in all patients with atrial fibrillation undergoing first-time, nonemergent cardiac surgery, and a new class I recommendation for left atrial appendage occlusion in all patients with atrial fibrillation undergoing first-time, nonemergent cardiac surgery. Further guidance is provided for patients with structural heart disease and atrial fibrillation being considered for transcatheter valve repair or replacement, as well as patients in need of isolated left atrial appendage management who are not candidates for surgical ablation. The importance of a multidisciplinary team assessment, treatment planning, and long-term follow-up are reiterated in this clinical practice guideline with a class I recommendation, along with the other recommendations from the 2017 guidelines that remained unchanged in their class of recommendation and level of evidence.
引用
- Wyler von Ballmoos MC, Hui DS, Mehaffey JH, et al. The Society of Thoracic Surgeons 2023 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg. 2024. PMID: 38286206. doi:10.1016/j.athoracsur.2024.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。